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1. Introduction 
Both Ca 2÷ and cyclic AMP play roles as intracellu- 
lar messengers which regulate the release of insulin 
from ~-cells of Langerhans' i lets (reviews [1,2]). The 
principal mediator of cyclic AMP has been identified 
as cyclic AMP-dependent protein kinase (protein 
kinase A) [3] and this species of protein kinase 
has been found in islets [4]. In contrast, possible 
factors mediating the regulatory properties of Ca 2+ 
are far less understood. Calmodulin has been identi- 
fied in rat pancreatic slets [5], and a calmodulin- 
dependent protein kinase has also been found in 
hamster insulinoma ceils [6]. Another line of evidence 
has shown that PI turns over rapidly during the acti- 
vation of islets by high concentrations of glucose 
[7-9]. This PI turnover has been proposed to be inti- 
mately related to glucose-induced insulin release 
[7-9], but the definitive mechanism involved has not 
yet been clarified. In [ 10,11 ], a new species of pro- 
tein kinase (protein kinase C) was described which 
absolutely requires Ca 2+ and phospholipid. Protein 
kinase C is usually present as an inactive form, but is 
activated by diacylglycerol which may be transiently 
produced from PI during its receptor-linked turnover 
[12,13]. In [14-16], protein kinase C was shown to 
play an indispensable role in the thrombin-induced 
release of serotonin in human platelets. To facilitate 
our understanding of the insulin release mechanism, 
Abbreviations: PI, phosphatidylinositol; PS, phosphatidyl- 
serine; PC, phosphatidylcholine; PE, phosphatidylethanol- 
amine; PA, phosphatidic a id; EGTA, ethylene glycol bis- 
(#-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
these studies were done to examine and characterize 
protein kinase C in rat pancreas i lets of Langerhans. 
2. Materials and methods 
Male Sprague-Dawley rats (150-250 g body wt) 
were used. Pancreatic slets were isolated as in [17]. 
Clostridium perfringens phospholipase C was obtained 
from Sigma. Chlorpromazine hydrochloride and dibu- 
caine hydrochloride were kindly donated by Shionogi 
Research Laboratory and Teikoku Chemical Industry, 
respectively. PS was a generous gift from Drs T. Fujii 
and A. Tamura, Kyoto College of Pharmacy. Syn- 
thetic diolein was purchased from Nakarai Chemicals. 
[7.32p] ATP, calf thymus H1 histone, various lipids, 
and other chemicals employed for the present studies 
were prepared as specified in [10-16]. All reagents 
were taken up in water which was prepared by a dou- 
ble distillation apparatus followed by passing through 
a Chelex 100 column to remove Ca 2÷ as in [13]. 
2.1. Determination of  insulin release 
The islets were preincubated for 45 min at 37°C in 
a Krebs Ringer bicarbonate buffer supplemented with 
0.25% bovine serum albumin and 3.75 mM glucose 
under the gas phase of 95% 02 and 5% CO2. Incuba- 
tion was performed in the presence of test substances 
for 30 min. Insulin concentration in the medium was 
measured by the polyethylene glycol radioimmuno- 
assay [18]. 
2.3. Assay for P! turnover 
PI turnover was assayed by measuring the incorpo- 
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Table 1 
Enhancement of 3~P-incorporation nto PI and insulin release by a high concentration f glucose 
32P-Incorporation into Insulin release 
(~unit. islet -1 . h -I ) 
PI (%) PC (%) PE (%) 
3.75 mM glucose 30.2 + 0.9 30.0 ± 4.5 36.0 + 1.6 14.4 + 4.8 
16.7 mM glucose 49.6 + 3.4 26.0 + 4.5 24.4 + 7.8 293.1 + 46.1 
The numbers of 32P-incorporation into each phospholipid are expressed as percent of total radio- 
activity that was incorporated into the phospholipid fraction as 100. The results are means ± SEM 
for triplicate xperiments 
ration of a2p into PI as in [19]. The islets were prein- 
cubated with 100/aCi of a2P i for 90 min under the 
above conditions except hat KH2PO4 was omitted 
from the buffer. The islets were than incubated with 
test substances for 60 min. Phospholipids were 
extracted from the islets as in [7], and PI was sepa- 
rated from other phospholipids by silica gel thin-layer 
chromatography as in [10]. The area corresponding 
to PI was scraped into a vial and the radioactivity was 
determined. 
2.3. Assay for protein kinases C and A 
Protein kinase C was assayed by measuring the 
incorporation of 32p from ['y-32P]ATP into calf thy- 
mus HI histone in the presence of Ca 2÷, PS and 
diolein. The complete reaction mixture (0.25 ml) con- 
rained 5/amol Tris-HC1 at pH 7.5, 1.25/amol magne- 
sium acetate, 50/ag H1 histone, 2.5 nmol [7-32P]ATP 
(5 -10  × l0  s cpm/nmol), 0.25/amol CaCI2, 2/~g PS 
and 0.2/ag diolein. Incubation was carried out for 
5 min at 30°C. The reaction was stopped by the addi- 
tion of 25% trichloroacetic acid and the acid-precipi- 
table radioactivity was determined as in [ 10]. Protein 
kinase A was similarly assayed except hat 250 pmol 
cyclic AMP was added instead of Ca 2÷, PS and diolein. 
2.4. Determinations 
The radioactivity of 32P-samples was determined 
using a Packard Tri-Carb liquid scintillation spectrom- 
eter, model 3320, with Bray's solution [20]. Sedi- 
mentation coefficient and Mr-values were estimated 
as in [21]. Protein was determined as in [22] with 
bovine serum albumin as a standard. 
3. Results and discussion 
When islets were incubated with high concentra- 
tions of glucose (16.7 mM), 32p-incorporation into PI 
was specifically increased, and the relative ratios of 
various phospholipid labelling are shown in table 1. 
32p-Incorporation into other phospholipids such as PC 
and PE was not increased under these conditions. This 
result agrees with that in [7]. Such a relative nhance- 
ment of a2P-incorporation into PI was also observed 
when the islets were incubated with bacterial phos- 
pholipase C instead of high concentrations of glucose 
as shown in table 2. Presumably, bacterial phospho- 
lipase C reacted with various membrane phospholipids 
and produced iacylglycerol, but the latter compound 
was converted more predominantly to PI by way of 
its resynthetic pathway. Bacterial phospholipase C 
Table 2 
Enhancement of 32P-incorporation into PI and insulin release by bacterial 
phospholipase C 
32 P-Incorporation i to 
PI (%) PC (%) PE (%) 
Insulin release 
(#unit. islet -1 . h -~) 
3.75 mM glucose 30.1 ± 0.6 30.1 ± 3.3 31.2 -+ 1.7 13.3 ± 2.8 
3.75 mM glucose 
+ 0.4 #g/ml 
phospholipase C 47.5 ± 4.2 26.0 ± 4.5 24.6 ± 4.2 236.7 ± 25.5 
The numbers of 32P-incorporation into each phospholipid are expressed as % of 
total radioactivity hat was incorporated into the phospholipid fraction as 100. 
The results axe means _+ SEM for triplicate xperiments 
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also induced insulin release as shown in table 2. This 
insulin release, however, was not simply due to the 
disruption of islet ceils, since other subceUular consti- 
tuents did not measurably eak into the medium. 
These results imply that diacylglycerol formation 
may be intimately related to the regulation of insulin 
release. 
We next examined whether diacylglycerol-activated 
protein kinase C was present in islets of l.angerhans. 
Islets were subjected to sonication in a buffer given in 
fig.l, and the sonicate was centrifuged for 60 min at 
100 000 X g. The supernatant was then analyzed by 
sucrose density gradient ultracentrifugation under the 
conditions pecified. When each fraction was assayed 
for protein kinase in the presence of 1/aM cyclic AMP, 
a small peak appeared in fractions 10-13. This small 
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Fig.1. Analysis of protein kinases in pancreatic slets on 
sucrose density gradient ultracentrifugation. About 300 islets 
were disrupted by sonication with a Kontes sonifier, model 
K881440, for 30 s at 0°C in 0.3 ml 10 mM potassium phos- 
phate buffer, at pH 7.0, containing 2 mM EDTA, 3 mM 
EGTA, and 10 mM .2-mercaptoethanol. Thesonicate was cen- 
trifuged for 60 min at 100 000 X g. The supernatant (0.25 ml, 
100 ~g protein) was layered over a 4.8 ml linear gradient of 
5-20% sucrose stablished in 20 mM Tris-HCl, at pH 7.5, 
containing 0.1 mM EDTA, 0.1 mM EGTA and 10 mM 2-mer- 
captoethanol, and was centrifuged at 4°C for 14 h at 
39 000 rev./min in the SW 50 rotor of a Beckman ultracentri- 
fuge, model L5-50. After centrffugation, fractions of 0.2 ml 
each were collected by punching ahole in the bottom of the 
tube. A 50 ~1 aliquot of each fraction was employed for pro- 
tein kinase A and C assays under standard conditions: 
(o - -o )  with Ca 2÷, PS and diolein; (A- - -A) with cyclic AMP; 
(o - -o )  with 0.5 mM EGTA instead of Ca 2÷, PS, diolein or 
cyclic AMP. 
peak bound cyclic AMP and was identified as protein 
kinase A. Next, all fractions were assayed for protein 
kinase in the presence of 1 mM CaC12, 2/lg PS and 
0.2/ag diolein. A large single symmetrical peak 
appeared in fractions 13-15. This peak, that was not 
detected inthe absence of these 3 activators, was iden- 
tified as protein kinase C. The active fractions were 
collected and directly employed for subsequent 
studies. This enzyme showed an S-value of ~5.1, 
which corresponded to 77 000 M r. 
Protein kinase C obtained in this way showed max- 
imum enzymatic activity in the simultaneous presence 
of Ca 2÷, PS and unsaturated diacylglycerol, diolein in 
this experiment, asshown in table 3. When either one 
of these activators was omitted, the enzymatic activ- 
ity was dramatically decreased. The metal require- 
ment for protein kinase C activation was very specific 
for Ca 2÷, and other divalent cations uch as Mg 2÷, 
Mn 2÷, Sr 2÷, Ni 2÷ and Co 2. were not effective. PS could 
not be replaced by other phospholipids such as PI, PE, 
PC and PA. Diarachidonin and dilinolein were as effec- 
tive as diolein, but diacylglycerols possessing 2 satu- 
rated fatty acids such as distearin and dipalmitin were 
far less effective. Monoacylglycerol, triacylglycerol, 
free fatty acid and cholesterol were totally inactive in 
this capacity. Calmodulin showed no effect over a 
wide range of concentrations. These properties of the 
islet protein kinase C were very similar to those of the 
enzyme originally found in rat brain soluble fraction 
[10-13]. 
In the last set of experiments, the effects of some 
phospholipid-interacting drugs such as chlorproma- 
zinc and dibucaine on islets protein kinase C were 
examined. Table 4 shows that these drugs inhibited 
the islet protein kinase as well as glucose-induced insu- 
Table 3 
Activation of islet protein kinase C by Ca 2÷, PS, and 
diacylglycerol 
Assay system Protein kinase 
act. (cpm) 
Complete system 12 870 ± 640 
-enzyme 0 
-Ca 2÷ + 0.5 mM EGTA 1980 ± 95 
-PS 510 ± 60 
-Diolein 2060 ± 110 
A 20/~1 aliquot of active fractions in fig.l was employed for 
protein kinase assay. For the complete system 2 X 10 -s M 
CaCI2, 2/~g PS, and 0.2/~g diolein were employed. The results 
are means ± SEM for triplicate xperiments 
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Table 4 
Inhibition by chlorpromazine and dibucaine of protein kinase C and 
glucose-induced insulin release 
Protein kinase C Insulin release 
act. (cpm) (#unit. islet -t . 0.5 h -1 ) 
None 3730 -+ 160 142.4 ± 20.2 
Chlorpromazine 
(0.05 mM) 1870 ± 80 73.7 ± 9.2 
(0.10 mM) 1240 ± 90 31.7 ± 2.2 
Dibucaine 
(0.25 mM) 1610 ± 85 99.7 ± 6.8 
(0.50 mM) 1370 ± 65 82.6 ± 5.7 
The results are means • SEM for triplicate xperiments 
lin release in parallel. Chlorpromazine was more effec- 
tive than dibucaine. 
The above results eem to suggest that PI turnover 
is coupled to the activation of protein kinase C in glu- 
cose-stimulated islets as described for thrombin-stim- 
ulated platelets [ 14-16] ,  since unsaturated diacyl- 
glycerol markedly activates this protein kinase in the 
presence of PS and Ca 2÷. It may be noted that some 
phospholipid-interacting drugs such as chlorproma- 
zinc and dibucaine inhibit both activation of protein 
kinase C and insulin release. Although it is generally 
accepted that these drugs interact with calmodulin 
and thereby inhibit calmodulin-dependent cellular 
processes [23], protein kinase C may be another tar- 
get of these drugs within the cell. The precise role of 
this protein kinase in regalating islet cell functions 
may be clarified by further investigations. 
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